We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+11.71%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$461B
AUM Growth
+$24.9B
Cap. Flow
-$12.1B
Cap. Flow %
-2.62%
Top 10 Hldgs %
40.03%
Holding
5,800
New
615
Increased
1,596
Reduced
2,751
Closed
340

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$2.34B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.65B
3
TSLA icon
Tesla
TSLA
+$1.45B
4
QQQ icon
Invesco QQQ Trust
QQQ
+$1.01B
5
AAPL icon
Apple
AAPL
+$833M

Sector Composition

Rank Sector Weight
1 Technology 20.48%
2 Financials 7.27%
3 Consumer Discretionary 6.82%
4 Communication Services 5.06%
5 Healthcare 4.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEPH icon
5076
Nephros
NEPH
$47.6M
$501 ﹤0.01%
+106
New +$416
JFIN
5077
Jiayin Group
JFIN
$131M
$495 ﹤0.01%
48
EMO
5078
ClearBridge Energy Midstream Opportunity Fund
EMO
$1.04B
$494 ﹤0.01%
11
-46
-81% -$2.17K
GYRO icon
5079
Gyrodyne
GYRO
$11.8M
$481 ﹤0.01%
+48
New +$474
BCS icon
5080
Barclays
BCS
$94.2B
$475 ﹤0.01%
23
TBLA icon
5081
Taboola.com
TBLA
$1.12B
$443 ﹤0.01%
130
-33,194
-100% -$114K
CDLX icon
5082
Cardlytics
CDLX
$22.4M
$435 ﹤0.01%
18
-1,373
-99% -$22.9K
CRON
5083
Cronos Group
CRON
$1.11B
$431 ﹤0.01%
155
-60,409
-100% -$142K
EWD icon
5084
iShares MSCI Sweden ETF
EWD
$593M
$425 ﹤0.01%
9
ARKG icon
5085
ARK Genomic Revolution ETF
ARKG
$1.78B
$417 ﹤0.01%
15
-15,586
-100% -$394K
NA
5086
Nano Labs
NA
$42M
$410 ﹤0.01%
76
AGM.A icon
5087
Federal Agricultural Mortgage Class A
AGM.A
$1.77B
$372 ﹤0.01%
+3
New +$406
GRWG icon
5088
GrowGeneration
GRWG
$85.9M
$369 ﹤0.01%
197
-15,183
-99% -$20.8K
LIQT icon
5089
LiqTech
LIQT
$23.7M
$350 ﹤0.01%
+133
New +$283
UNCY icon
5090
Unicycive Therapeutics
UNCY
$138M
$349 ﹤0.01%
80
IMUX icon
5091
Immunic
IMUX
$192M
$335 ﹤0.01%
38
+26
+217% +$229
NUVB.WS
5092
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$331 ﹤0.01%
1,638
ADAP
5093
DELISTED
Adaptimmune Therapeutics
ADAP
$330 ﹤0.01%
2,534
HHS icon
5094
Harte-Hanks
HHS
$18.5M
$323 ﹤0.01%
+87
New +$314
CLIR icon
5095
ClearSign Technologies
CLIR
$26.6M
$311 ﹤0.01%
40
+35
+700% +$205
CODA icon
5096
Coda Octopus Group
CODA
$117M
$305 ﹤0.01%
+38
New +$300
ISPO
5097
DELISTED
Inspirato
ISPO
$296 ﹤0.01%
+100
New +$305
BW icon
5098
Babcock & Wilcox
BW
$1.32B
$293 ﹤0.01%
101
RAIN
5099
Rain Enhancement Technologies
RAIN
$12.2M
$288 ﹤0.01%
+52
New +$217
METCB icon
5100
Ramaco Resources Class B
METCB
$412M
$287 ﹤0.01%
18
+11
+157% +$152

Similar funds

Barclays's Q3 2025 Portfolio in Review

As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
  • Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
  • Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
  • Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
  • Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
  • Barclays opened 615 new positions and closed 340 in Q3 2025.
  • Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.

Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.